Title : Refractory and metastatic infantile fibrosarcoma harboring LMNA-NTRK1 fusion shows complete and durable response to crizotinib.

Pub. Date : 2019 Feb

PMID : 30709876






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Refractory and metastatic infantile fibrosarcoma harboring LMNA-NTRK1 fusion shows complete and durable response to crizotinib. Crizotinib neurotrophic receptor tyrosine kinase 1 Homo sapiens
2 In this report, we outline the use of integrative clinical sequencing (ICS) including RNA-seq in a patient with refractory, metastatic IFS to reveal an unusual fusion (LMNA-NTRK1), not detected by routine FISH testing, which was treated with oral crizotinib and resulted in a complete and durable long-term response. Crizotinib neurotrophic receptor tyrosine kinase 1 Homo sapiens